Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Principal Capital Public Company Limited (PRINC.BK)
Bangkok, TH
Principal Capital Public Company Limited primarily focuses on the administration and oversight of private healthcare facilities throughout Thailand. Its business operations extend to the hospitality sector, encompassing the management of hotels and serviced apartments. Additionally, the company is involved in the rental of office properties, along with broader real estate development and leasing activities. It also delivers professional management solutions for office buildings. Founded in 2000, this Bangkok-based entity operated as Metro Star Property Public Company Limited until it adopted its current designation in August 2013.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.58% | -1.15% | -2.82% | -14.85% | -7.53% | +1.18% | -13.13% | -62.77% | -58.85% | -39.86% | -56.12% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+6.3% Q1'26: +5.5% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-219.2% Q1'26: -14.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-8.3% Q1'26: -17.2% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%-4.4% Q1'26: -5.9% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%-2.0% Q1'26: -2.6% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×9.84× Q1'26: 13.46× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
|---|---|---|---|
| Revenue |
5.64B
est: 6.77B (-16.7%)
|
5.70B
est: 7.99B (-28.6%)
|
6.06B
est: 7.99B (-24.1%)
|
| EBITDA |
316.94M
est: 773.45M (-59.0%)
|
382.70M
est: 898.45M (-57.4%)
|
428.92M
est: 898.45M (-52.3%)
|
| EBIT |
-451.62M
est: -152.44M (-196.3%)
|
-271.76M
est: -32.56M (-734.6%)
|
-266.35M
est: -32.56M (-718.0%)
|
| Net Income |
-690.30M
|
351.44M
|
-406.05M
|
| SGA |
1.31B
est: 1.66B (-21.0%)
|
1.44B
est: 1.88B (-23.4%)
|
1.44B
est: 1.88B (-23.5%)
|
| EPS |
-0.18
|
0.09
|
-0.11
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-12 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-11 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-08 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-06 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-05-05 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 7.1K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Tawan Chitchulanon | Executive Director | 390.0K | male |
| Panu Boonsombat | Executive Director | 390.0K | — |
| Tharin Eampetcharapong | Chief Financial Officer & Director | 300.0K | male |
| Achara Ratanaphunsri | Chief Internal Control & Compliance Officer | 181.7K | — |
| Jatuphol Chawapatnakul | Assistant Managing Director | — | male |
| Kanut Sirisuwat | Co-CEO, Chief Business Expansion Officer, Deputy COO & Director | — | male |
| Preeyaporn Aphiwartwittaya | Executive Director & Accounting Director | — | female |
| Tawan Juengsmarn | Assistant to MD, Chief Operating Officer & Executive Director | — | male |
| Thiranan Sangphungtham | Assistant Director of Legal & Government Relations | — | female |
| Varan Tiensong | Assistant Managing Director | — | — |
| Wareeporn Songsak | Chief People Officer | — | — |
| Wityavate Rakkulchon | Co-CEO & Executive Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PRINC.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
